National Planning Corporation’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-398
Closed -$709K 102
2017
Q3
$709K Buy
398
+19
+5% +$26.5K 0.06% 294
2017
Q2
$517K Buy
379
+40
+12% +$48.3K 0.04% 397
2017
Q1
$385K Hold
339
0.03% 447
2016
Q4
$337K Buy
+339
New +$269K 0.03% 473
2016
Q3
Sell
-343
Closed -$246K 666
2016
Q2
$246K Buy
+343
New +$194K 0.02% 547
2016
Q1
Sell
-354
Closed -$219K 656
2015
Q4
$219K Buy
+354
New +$354K 0.02% 602

Other funds holding BLUE

National Planning Corporation's BLUE Position: Q4 2017 in Review

National Planning Corporation sold out of bluebird bio (BLUE) in Q4 2017, closing a stake of 398 shares — an estimated $709K sold.

National Planning Corporation first reported a position in BLUE in Q4 2015 and held it in 6 quarters. The position peaked at $709K in Q3 2017. 296 funds tracked by Wall St. Rank hold BLUE as of Q4 2017.

  • National Planning Corporation reported no remaining bluebird bio position as of Q4 2017 after selling out during the quarter.
  • National Planning Corporation sold 398 bluebird bio shares in Q4 2017, an estimated $709K.
  • National Planning Corporation first reported a position in bluebird bio in Q4 2015 and held it in 6 quarters.
  • National Planning Corporation's bluebird bio position peaked at $709K in Q3 2017.
  • 296 funds tracked by Wall St. Rank held bluebird bio as of Q4 2017.

Based on National Planning Corporation's 13F filing for Q4 2017, filed 14 Feb 2018.